BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 26248567)

  • 1. Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men.
    Sharma R; Oni OA; Gupta K; Chen G; Sharma M; Dawn B; Sharma R; Parashara D; Savin VJ; Ambrose JA; Barua RS
    Eur Heart J; 2015 Oct; 36(40):2706-15. PubMed ID: 26248567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of Testosterone Normalization to Mortality and Myocardial Infarction in Men With Previous Myocardial Infarction.
    Oni OA; Dehkordi SHH; Jazayeri MA; Sharma R; Sharma M; Masoomi R; Sharma R; Gupta K; Barua RS
    Am J Cardiol; 2019 Oct; 124(8):1171-1178. PubMed ID: 31409450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of Testosterone Levels After Testosterone Replacement Therapy Is Associated With Decreased Incidence of Atrial Fibrillation.
    Sharma R; Oni OA; Gupta K; Sharma M; Sharma R; Singh V; Parashara D; Kamalakar S; Dawn B; Chen G; Ambrose JA; Barua RS
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28487389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System.
    Anderson JL; May HT; Lappé DL; Bair T; Le V; Carlquist JF; Muhlestein JB
    Am J Cardiol; 2016 Mar; 117(5):794-9. PubMed ID: 26772440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalization of Testosterone Levels After Testosterone Replacement Therapy Is Not Associated With Reduced Myocardial Infarction in Smokers.
    Oni OA; Sharma R; Chen G; Sharma M; Gupta K; Dawn B; Sharma R; Parashara D; Savin VJ; Cherian G; Ambrose JA; Barua RS
    Mayo Clin Proc Innov Qual Outcomes; 2017 Jul; 1(1):57-66. PubMed ID: 30225402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency.
    Cheetham TC; An J; Jacobsen SJ; Niu F; Sidney S; Quesenberry CP; VanDenEeden SK
    JAMA Intern Med; 2017 Apr; 177(4):491-499. PubMed ID: 28241244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Testosterone Replacement Therapy and the Incidence of DVT and Pulmonary Embolism: A Retrospective Cohort Study of the Veterans Administration Database.
    Sharma R; Oni OA; Chen G; Sharma M; Dawn B; Sharma R; Parashara D; Savin VJ; Barua RS; Gupta K
    Chest; 2016 Sep; 150(3):563-71. PubMed ID: 27179907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men with Low Testosterone Levels: A Cohort Study.
    Loo SY; Azoulay L; Nie R; Dell'Aniello S; Yu OHY; Renoux C
    Am J Med; 2019 Sep; 132(9):1069-1077.e4. PubMed ID: 30953635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone therapy and risk of myocardial infarction: a pharmacoepidemiologic study.
    Etminan M; Skeldon SC; Goldenberg SL; Carleton B; Brophy JM
    Pharmacotherapy; 2015 Jan; 35(1):72-8. PubMed ID: 25582846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone Therapy and Risk of Acute Myocardial Infarction in Hypogonadal Men: An Administrative Health Care Claims Study.
    Li H; Mitchell L; Zhang X; Heiselman D; Motsko S
    J Sex Med; 2017 Nov; 14(11):1307-1317. PubMed ID: 29110802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.
    Vigen R; O'Donnell CI; Barón AE; Grunwald GK; Maddox TM; Bradley SM; Barqawi A; Woning G; Wierman ME; Plomondon ME; Rumsfeld JS; Ho PM
    JAMA; 2013 Nov; 310(17):1829-36. PubMed ID: 24193080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study.
    Wallis CJ; Lo K; Lee Y; Krakowsky Y; Garbens A; Satkunasivam R; Herschorn S; Kodama RT; Cheung P; Narod SA; Nam RK
    Lancet Diabetes Endocrinol; 2016 Jun; 4(6):498-506. PubMed ID: 27165609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes.
    Muraleedharan V; Marsh H; Kapoor D; Channer KS; Jones TH
    Eur J Endocrinol; 2013 Dec; 169(6):725-33. PubMed ID: 23999642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In older men, higher plasma testosterone or dihydrotestosterone is an independent predictor for reduced incidence of stroke but not myocardial infarction.
    Yeap BB; Alfonso H; Chubb SA; Hankey GJ; Handelsman DJ; Golledge J; Almeida OP; Flicker L; Norman PE
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4565-73. PubMed ID: 25268392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary sodium and potassium excretion and risk of cardiovascular events.
    O'Donnell MJ; Yusuf S; Mente A; Gao P; Mann JF; Teo K; McQueen M; Sleight P; Sharma AM; Dans A; Probstfield J; Schmieder RE
    JAMA; 2011 Nov; 306(20):2229-38. PubMed ID: 22110105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term incidence of myocardial infarct, stroke, and mortality in patients operated on for abdominal aortic aneurysms.
    Eldrup N; Budtz-Lilly J; Laustsen J; Bibby BM; Paaske WP
    J Vasc Surg; 2012 Feb; 55(2):311-7. PubMed ID: 22051869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study.
    Subherwal S; Patel MR; Kober L; Peterson ED; Bhatt DL; Gislason GH; Olsen AM; Jones WS; Torp-Pedersen C; Fosbol EL
    Eur J Prev Cardiol; 2015 Mar; 22(3):317-25. PubMed ID: 24398369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low testosterone and sexual symptoms in men with acute coronary syndrome can be used to predict major adverse cardiovascular events during long-term follow-up.
    Chmiel A; Mizia-Stec K; Wierzbicka-Chmiel J; Rychlik S; Muras A; Mizia M; Bienkowski J
    Andrology; 2015 Nov; 3(6):1113-8. PubMed ID: 26460501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment and risk of cardiovascular events and mortality.
    O'Donnell M; Teo K; Gao P; Anderson C; Sleight P; Dans A; Marzona I; Bosch J; Probstfield J; Yusuf S
    Eur Heart J; 2012 Jul; 33(14):1777-86. PubMed ID: 22551598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease.
    Boden WE; Miller MG; McBride R; Harvey C; Snabes MC; Schmidt J; McGovern ME; Fleg JL; Desvigne-Nickens P; Anderson T; Kashyap M; Probstfield JL
    Am Heart J; 2020 Jun; 224():65-76. PubMed ID: 32335402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.